ALFA Finder| Value | ₹28.01 Cr |
|---|---|
| Execution period | half year ended March 31, 2026 |
BSE filing, BSE: 543499. Summary written from the filing by ALFA Finder's alert engine.
Achyut Healthcare Ltd: key numbers
- Share price
- ₹7.85
- Market cap
- ₹189.5 Cr
- Revenue (annual)
- ₹11.59 Cr
- Net profit (annual)
- ₹0.32 Cr
- P/E (TTM)
- 746.9×Sector 43.8×
- Promoter holding
- 47.40%+0.00% QoQ
- FII holding
- 5.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Achyut Healthcare Ltd
All →Achyut Healthcare Q2 FY27 Results: Net Profit ₹0 Cr
Achyut Healthcare Ltd reported revenue from operations of ₹1.7 Cr (-32.0% YoY) and net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Achyut Healthcare Board Meeting Date
Achyut Healthcare will hold a board meeting on 26 October 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. The trading window remains closed until 48 hours after results declaration.
Achyut Healthcare Other Announcement
Achyut Healthcare Ltd submitted its quarterly shareholding pattern filing for the period ending September 30, 2026, pursuant to SEBI Regulation 31(1)(b) requirements.
Achyut Healthcare Management Change
Achyut Healthcare Ltd announced the re-appointment of Mr. Jigen J. Modi as Managing Director for a five-year term, following approval at the 31st Annual General Meeting.
Achyut Healthcare Annual General Meeting
Achyut Healthcare Limited conducted its 31st Annual General Meeting on September 29, 2026. Key resolutions included adopting audited financial statements and re-appointing directors and the Managing Director.
Achyut Healthcare Management Change
Achyut Healthcare re-appointed Jigen J. Modi as Executive Director and Sonu L. Jain and Rutvik S. Thakkar as Independent Directors for 60-month terms.
Other fund raise announcements
All →Om Metallogic Fund Raise
Om Metallogic Ltd intimated a board meeting on 14 November 2026 to approve rights issue issue price, entitlement ratio, record date and issue dates. The rights issue follows BSE in-principle approval.
Virinchi Fund Raise of ₹30 Cr
Virinchi's board approved a Rs 30 Crore preferential issue of 2 crore convertible warrants at Rs 15 each. Subject to EGM approval, allottees include promoter Viswanath Kompella.
- Value
- ₹30.00 Cr
- Execution
- Warrant tenure not exceeding 18 months from allotment
IIFL Finance Fund Raise of ₹6,414 Cr
IIFL Finance's board approved a preferential issue of convertible preference shares and warrants worth Rs.6,414.20 Crore. Shareholder approval is needed at a 4 December EGM.
- Value
- ₹6,414 Cr
Bajaj Finance Fund Raise of ₹5,800 Cr
Bajaj Finance's special committee approved issuing 5.74 crore warrants to promoter Bajaj Finserv at ₹1,010 each. The issue raises about ₹5,800 crore.
- Value
- ₹5,800 Cr
Cholamandalam Investment & Finance Company Fund Raise of ₹5,000 Cr
Cholamandalam Investment sent shareholders a postal ballot notice seeking approval for a Rs 5,000 crore QIP. E-voting runs November 10 to December 9, 2026.
- Value
- ₹5,000 Cr
- Execution
- Allotment to be completed within 365 days of shareholder approval
HB Leasing & Finance Co Fund Raise
HB Leasing's board discussed fund-raising options on November 9, 2026, including equity and preference shares. No quantum or pricing is decided; advisers will be consulted.